Author

William Pinney

Observed name: William B. Pinney

Institutions: Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology

Observed institutions: Boston Children's Hospital, Harvard University, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology

OpenAlex ID: A5031744682

Local delivery of cell surface-targeted immunocytokines programs systemic antitumor immunity

2024 · Luciano Santollani, Laura Maiorino, et al. · Nature Immunology · 57

Induction of antigen-specific tolerance by nanobody–antigen adducts that target class-II major histocompatibility complexes

2021 · Novalia Pishesha, Thibault Harmand, et al. · Nature Biomedical Engineering · 48

A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants

2021 · Novalia Pishesha, Thibault J. Harmand, et al. · Proceedings of the National Academy of Sciences · 35

Asparaginyl Ligase-Catalyzed One-Step Cell Surface Modification of Red Blood Cells

2021 · Thibault J. Harmand, Novalia Pishesha, et al. · ACS Chemical Biology · 35

Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms

2022 · Novalia Pishesha, Thibault Harmand, et al. · Proceedings of the National Academy of Sciences · 19

CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs

2024 · Joseph R. Palmeri, Brianna M. Lax, et al. · Nature Communications · 18

Diverse priming outcomes under conditions of very rare precursor B cells

2025 · Patrick J. Madden, Ester Marina-Zárate, et al. · Immunity · 15

Engineering hyaluronic acid-binding cytokines for enhanced tumor retention and safety

2026 · Elizabeth Fink, William Pinney, et al. · bioRxiv (Cold Spring Harbor Laboratory)

866 Computational stabilization of a CD45-targeted IL-21 for intratumoral immunotherapy

2025 · William Pinney, Elizabeth Fink, et al. · Journal for ImmunoTherapy of Cancer

CD45 sequestration lowers the signaling threshold in lymphocytes and enhances anti-tumor immunity

2025 · Lauren Duhamel, Yiming J. Zhang, et al. · bioRxiv (Cold Spring Harbor Laboratory)

1224 Tregs constrain CD8 + T cell priming required for curative intratumorally anchored anti-4–1BB immunotherapy

2023 · Joseph R Palmeri, Brianna M Lax, et al. · Journal for ImmunoTherapy of Cancer

Works count: 11

Citation count: 227

H-index: 7

I10-index: 7